Med Business World

Your source for healthcare business

cardiovascular

Winter mornings increase the risk of cardiovascular conditions: Dr. Manjinder Sandhu

According to a German study, temperature drops (up to 2.9 degrees over 24 hours) result in an increase in heart attacks by 11% The surge in blood pressure during cold climate causes rupture, heart attacks, blood clotting and blocking of…

Dapagliflozin significantly reduced the risk of cardiovascular death or worsening of heart failure in patients with mildly reduced or preserved ejection fraction in DELIVER Phase III trial

Detailed results from the DELIVER Phase III trial showed AstraZeneca’s dapagliflozin significantly reduced the composite of cardiovascular (CV) death or worsening heart failure (HF) in patients with HF and mildly reduced or preserved ejection fraction (EF), compared to placebo. The results…